Product Information
6-Iodochroman-4-Ol is a monoclonal antibody that binds to the vascular endothelial growth factor receptor 2 (VEGFR2) and inhibits the downstream signal transduction pathway. It has been shown to be effective in the treatment of renal cell carcinoma in animal models. 6-Iodochroman-4-Ol has also been shown to reduce the number of tumour vessels, which may be due to its ability to inhibit angiogenesis. This drug has also been used for treatment of paediatric patients with metastatic renal cell carcinomas. The efficacy of this drug is reduced by elevated serum levels of TNF-α, which may be due to increased production or decreased clearance.
Chemical properties
Technical inquiry about: 3D-LHA63932 6-Iodochroman-4-Ol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
